Willingness to pay for antiretroviral therapy, viral load, and premium services; A contingent valuation survey of people living with HIV in southern Nigeria.

Autor: Olusola Sanwo, Ihoghosa Iyamu, Augustine Idemudia, Titilope Badru, Sylvia Ekponimo, Dorothy Oqua, Olusesan A Makinde, Gambo G Aliyu, Abimbola Kola-Jebutu, Jemeh Egwuagu-Pius, Chika Obiora-Okafo, Moses Bateganya, Iorwakwagh Apera, Satish Raj Pandey, Hadiza Khamofu

Publikováno v: PLoS ONE, Vol 18, Iss 11, p e0289507 (2023)

BackgroundWith stagnating funding for HIV and AIDS control programs in Nigeria, alternative funding models for antiretroviral therapy (ART) including out of pocket payment are being considered to sustain momentum epidemic control targets. We assessed

Externí odkaz: https://doaj.org/article/487e91de30204211b112bb086e934131

Evaluation of the clinical outcomes of the Test and Treat strategy to implement Treat All in Nigeria: Results from the Nigeria Multi-Center ART Study.

Autor: Kristen A Stafford, Solomon F Odafe, Julia Lo, Ramat Ibrahim, Akipu Ehoche, Mercy Niyang, Gambo G Aliyu, Bola Gobir, Dennis Onotu, Ademola Oladipo, Ibrahim Dalhatu, Andrew T Boyd, Otse Ogorry, Lawal Ismail, Manhattan Charurat, Mahesh Swaminathan

Publikováno v: PLoS ONE, Vol 14, Iss 7, p e0218555 (2019)

In December 2016, the Nigerian Federal Ministry of Health updated its HIV guidelines to a Treat All approach, expanding antiretroviral therapy (ART) eligibility to all individuals with HIV infection, regardless of CD4+ cell count, and recommending AR

Externí odkaz: https://doaj.org/article/bfb240e677d64364ac6b488a42674ee5

The Burden of HIV, Hepatitis B and Hepatitis C by Armed Conflict Setting: The Nigeria AIDS Indicator and Impact Survey, 2018

Autor: Hamisu M. Salihu, Rafeek A Yusuf, Sani H. Aliyu, Gambo G. Aliyu, Deepa Dongarwar, Muktar H. Aliyu, Akipu Ehoche

Publikováno v: Annals of Global Health, Vol 87, Iss 1 (2021)
Annals of Global Health

Background: Against a background of security challenges, Nigeria conducted recently the largest population-based HIV survey in the world to ascertain the burden of the HIV disease in the country. We evaluated the main outcomes of the survey and the l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da0e46bcd6ba517734990ab8c93c9846
https://annalsofglobalhealth.org/articles/3226

HIV epidemic among key populations in Nigeria: results of the integrated biological and behavioural surveillance survey (IBBSS), 2020-2021.

Autor: Emmanuel F; Institute for Global Public Health, University of Manitoba, Winnipeg, Manitoba, Canada., Ejeckam CC; Program, Institute for Global Public Health, University of Manitoba (Nigeria Office), Abuja, Federal Capital Territory, Nigeria bukana888@gmail.com., Green K; Institute for Global Public Health, University of Manitoba, Winnipeg, Manitoba, Canada., Adesina AA; Monitoring and Evaluation, Institute for Global Public Health, University of Manitoba (Nigeria Office), Abuja, Federal Capital Territory, Nigeria., Aliyu G; Management, National Agency for the Control of AIDS, Abuja, Nigeria., Ashefor G; Management, National Agency for the Control of AIDS, Abuja, Nigeria., Aguolu R; Research, Monitoring and Evaluation, National Agency for the Control of AIDS, Abuja, Nigeria., Isac S; Data Analysis, Institute for Global Public Health, University of Manitoba (Country Office), New Delhi, Delhi, India., Blanchard J; Community Health Sciences, Institute for Global Public Health, University of Manitoba , Winnipeg, Manitoba, Canada.

Publikováno v: Sexually transmitted infections [Sex Transm Infect] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.

HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia: Analysis of 14 cross-sectional population-based HIV Impact Assessment surveys in sub-Saharan Africa.

Autor: Edun O; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom., Okell L; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom., Chun H; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Bissek AZ; Division of Health Operations Research, Ministry of Public Health, Yaoundé, Cameroon.; Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Yaoundé, Cameroon., Ndongmo CB; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Yaoundé, Cameroon., Shang JD; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Yaoundé, Cameroon., Brou H; ICAP, Columbia University, Abidjan, Côte d'Ivoire., Ehui E; National AIDS Control Programme, Ministry of Health, Public Hygiene and Universal Health Coverage, Abidjan, Côte d'Ivoire., Ekra AK; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abidjan, Côte d'Ivoire., Nuwagaba-Biribonwoha H; ICAP at Columbia University and Department of Epidemiology, Mailman School of Public Health, Mbabane, Eswatini., Dlamini SS; Ministry of Health, Mbabane, Eswatini., Ginindza C; Central Statistical Office, Mbabane, Eswatini., Eshetu F; U.S. Centers for Disease Control and Prevention Division of Global HIV/TB, Center for Global Health, Addis Ababa, Ethiopia., Misganie YG; Ethiopian Public Health Institute, HIV/AIDS and TB Research Directorate, Addis Ababa, Ethiopia.; School of Medicine, Zhejiang University, Hangzhou, China., Desta SL; ICAP in Ethiopia, Mailman School of Public Health, Columbia University, Addis Ababa, Ethiopia., Achia TNO; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Nairobi, Kenya., Aoko A; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Nairobi, Kenya., Jonnalagadda S; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Nairobi, Kenya., Wafula R; National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya., Asiimwe FM; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Maseru, Lesotho., Lecher S; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Maseru, Lesotho., Nkanaunena K; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Lilongwe, Malawi., Nyangulu MK; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Lilongwe, Malawi., Nyirenda R; Department of HIV/AIDS, Ministry of Health, Lilongwe, Malawi., Beukes A; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Windhoek, Namibia., Klemens JO; Namibia Institute of Pathology Limited, Windhoek, Namibia., Taffa N; Ministry of Health and Social Services, Windhoek, Namibia., Abutu AA; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abuja, Nigeria., Alagi M; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abuja, Nigeria., Charurat ME; Center for International Health, Education, and Biosecurity (Ciheb), University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America., Dalhatu I; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Abuja, Nigeria., Aliyu G; National Agency for the Control of AIDS, Abuja, Nigeria., Kamanzi C; ICAP, Columbia University, Kigali, Rwanda., Nyagatare C; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Kigali, Rwanda., Rwibasira GN; HIV, STIs, Viral Hepatitis & OVDC Department, Rwanda Biomedical Center, Kigali, Rwanda., Jalloh MF; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Dar es Salaam, Tanzania., Maokola WM; National AIDS Control Programme, Tanzania Ministry of Health, Dar es Salaam, Tanzania., Mgomella GS; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Dar es Salaam, Tanzania., Kirungi WL; Ministry of Health, AIDS Control Programme, Kampala, Uganda., Mwangi C; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Kampala, Uganda., Nel JA; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Kampala, Uganda., Minchella PA; U.S. Centers for Disease Control and Prevention Division of Global HIV/TB, Center for Global Health, Lusaka, Zambia., Gonese G; Zimbabwe Technical Assistance, Training and Education Center for Health (Zim-TTECH), Harare, Zimbabwe., Nasr MA; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Harare, Zimbabwe.; Public Health Institute, Global Health Fellowship Program, United States of America., Bodika S; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Mungai E; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America.; eTeam, Somerset, New Jersey, United States of America., Patel HK; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Sleeman K; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Milligan K; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America.; Peraton, Herndon, Virginia, United States of America., Dirlikov E; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Voetsch AC; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Shiraishi RW; U.S. Centers for Disease Control and Prevention - Division of Global HIV/TB, Center for Global Health, Atlanta, Georgia, United States of America., Imai-Eaton JW; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.; Department of Epidemiology, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Apr 04; Vol. 4 (4), pp. e0003030. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).